Charleston Laboratories Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Charleston Laboratories General Information
Description
Developer of pain relief medicines designed to treat acute pain and reduce drug- and disease-induced nausea and vomiting. The company develops proprietary drug formulations featuring abuse-deterrent technologies and acetaminophen-free therapies, enabling healthcare providers to deliver effective pain management while reducing the risk of liver injury, misuse, and abuse.
Contact Information
Website
www.charlestonlabs.comCorporate Office
- 1150 South United States Highway 1
- Jupiter, FL 33477
- United States
Corporate Office
- 1150 South United States Highway 1
- Jupiter, FL 33477
- United States
Charleston Laboratories Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-May-2026 | Completed | Clinical Trials - Phase 3 | |||
| 7. Debt - PPP | 07-Apr-2020 | Completed | Clinical Trials - Phase 3 | |||
| 6. Debt - General | 25-Aug-2014 | Completed | Clinical Trials - Phase 3 | |||
| 5. Later Stage VC | 06-Aug-2014 | Completed | Clinical Trials - Phase 3 | |||
| 4. Grant | 08-Aug-2013 | Completed | Clinical Trials - Phase 3 | |||
| 3. Later Stage VC (Series B) | 01-Oct-2012 | Completed | Clinical Trials - Phase 3 | |||
| 2. Early Stage VC (Series A) | 22-Dec-2009 | $975K | $1.18M | Completed | Clinical Trials - Phase 3 | |
| 1. Early Stage VC | 03-Aug-2007 | $200K | $200K | Completed | Startup |
Charleston Laboratories Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Charleston Laboratories Patents
Charleston Laboratories Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170354603-A1 | Pharmaceutical compositions | Inactive | 10-Jun-2016 | ||
| US-20200054564-A1 | Pharmaceutical compositions | Inactive | 10-Jun-2016 | ||
| EP-3468558-A1 | Pharmaceutical compositions comprising an opioid analgesic and an antiemetic to treat pain | Inactive | 10-Jun-2016 | ||
| EP-3468558-A4 | Pharmaceutical compositions comprising an opioid analgesic and an antiemetic to treat pain | Inactive | 10-Jun-2016 | ||
| WO-2017214538-A1 | Pharmaceutical compositions comprising an opioid analgesic and an antiemetic to treat pain | Inactive | 10-Jun-2016 | A61K9/209 |
Charleston Laboratories Signals
Charleston Laboratories Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Daiichi Sankyo | Corporation | Minority |
Charleston Laboratories FAQs
-
When was Charleston Laboratories founded?
Charleston Laboratories was founded in 2007.
-
Where is Charleston Laboratories headquartered?
Charleston Laboratories is headquartered in Jupiter, FL.
-
What is the size of Charleston Laboratories?
Charleston Laboratories has 3 total employees.
-
What industry is Charleston Laboratories in?
Charleston Laboratories’s primary industry is Drug Discovery.
-
Is Charleston Laboratories a private or public company?
Charleston Laboratories is a Private company.
-
What is Charleston Laboratories’s current revenue?
The current revenue for Charleston Laboratories is .
-
How much funding has Charleston Laboratories raised over time?
Charleston Laboratories has raised $209M.
-
Who are Charleston Laboratories’s investors?
Daiichi Sankyo has invested in Charleston Laboratories.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process